ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

1-Methylpiperazine → 4-[5-(4-Methyl-piperazin-1-yl)-pyridin-3-yl]-2-(6-methyl-pyridin-2-yl)-7H-pyrrolo[2,3-d]pyrimidine

HRID 1878600
印刷

反応式

HRID 1878600 の反応式
Br[C:2]1[CH:3]=[C:4]([C:8]2[C:9]3[CH:23]=[CH:22][NH:21][C:10]=3[N:11]=[C:12]([C:14]3[CH:19]=[CH:18][CH:17]=[C:16]([CH3:20])[N:15]=3)[N:13]=2)[CH:5]=[N:6][CH:7]=1.[CH3:24][N:25]1[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]1.C1(P(C2CCCCC2)C2C=CC=CC=2C2C=CC=CC=2)CCCCC1.[Li+].C[Si]([N-][Si](C)(C)C)(C)C>C1COCC1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH3:24][N:25]1[CH2:30][CH2:29][N:28]([C:2]2[CH:3]=[C:4]([C:8]3[C:9]4[CH:23]=[CH:22][NH:21][C:10]=4[N:11]=[C:12]([C:14]4[CH:19]=[CH:18][CH:17]=[C:16]([CH3:20])[N:15]=4)[N:13]=3)[CH:5]=[N:6][CH:7]=2)[CH2:27][CH2:26]1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 531671-MethylpiperazineHCID 2733832Lithium hexamethyldisilazaneHCID 27342162-(Dicyclohexylphosphino)biphenylHCID 441944484-(5-Bromo-pyridin-3-yl)-2-(6-methyl-pyridin-2-yl)-7H-pyrrolo[2,3-d]pyrimidine

生成物 1

HCID 687361094-[5-(4-Methyl-piperazin-1-yl)-pyridin-3-yl]-2-(6-methyl-pyridin-2-yl)-7H-pyrrolo[2,3-d]pyrimidine

試薬・触媒・溶媒

2
HCID 9811564Bis(dibenzylideneacetone)palladium触媒HCID 8028Tetrahydrofuran溶媒

実験手順

To a solution of 4-(5-bromo-pyridin-3-yl)-2-(6-methyl-pyridin-2-yl)-7H-pyrrolo[2,3-d]pyrimidine (Example 16) (1 eq, 0.81 mmol, 300 mg) in THF (5 ml), 1-methylpiperazine (Sigma-Aldrich, St. Louis, USA) (1.25 eq, 1.01 mmol, 0.114 ml), Pd2(dba)3 (0.04 eq, 0.032 mmol, 29.7 mg), and 2-(dicyclohexylphosphino)biphenyl (0.08 eq, 0.065 mmol, 25.5 mg) are added. After addition of LHMDS (1 M in THF, 2.2 eq, 1.8 mmol, 1.8 ml) the mixture is refluxed for 5 h, cooled down and quenched by addition of aqueous HCl solution (2M, 5 ml). The mixture is adjusted to pH 6 using aqueous NaOH solution and washed with ethyl acetate. The aqueous layer is adjusted to pH 12 and extracted with EtOAc. The organic layer is washed with brine, dried with MgSO4, filtered, and concentrated. Purification by reversed phase HPLC is giving the title compound, [M+H]+=422; 1H-NMR (400 MHz, CD3OD): δ 9.20 (s, 1H), 9.06-9.03 (m, 2H), 8.74 (d, 1H), 8.67 (t, 1H), 8.04 (d, 1H), 7.99 (d, 1H), 7.23 (d, 1H), 4.41 (m, 2H), 3.76 (m, 2H), 3.60 (m, 2H), 3.43 (m, 2H), 3.04 (s, 3H), 3.03 (s, 3H).

後処理

  1. temperatureis refluxed for 5 h
  2. temperaturecooled down
  3. customquenched by addition of aqueous HCl solution (2M, 5 ml)
  4. washwashed with ethyl acetate
  5. extractionextracted with EtOAc
  6. washThe organic layer is washed with brine
  7. dry with materialdried with MgSO4
  8. filtrationfiltered
  9. concentrationconcentrated
  10. customPurification by reversed phase HPLC

出典と根拠

ORDレコード
ord-912c0190f0cf43138cd26bfce24ed7fc
出典データセット
uspto-grants-2012_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08314112B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート